Home › Funds › Point72 Asset Management › SUPN
Point72 Asset Management position in SUPN
SUPERNUS PHARMACEUTICALS · Health Care
Latest position (Q1 2026)1.32M sh
Reported value held$68.16M
Portfolio Weight0.09%
First reportedQ1 2023
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2023 | 755 | $27.35K | New |
| Q1 2024 | 127.82K | $4.36M | New |
| Q2 2024 | 136.34K | $3.65M | Add |
| Q4 2024 | 26.83K | $970.09K | New |
| Q1 2025 | 318.90K | $10.44M | Add |
| Q2 2025 | 507.79K | $16.01M | Add |
| Q3 2025 | 1.76M | $84.18M | Add |
| Q4 2025 | 2.26M | $112.56M | Add |
| Q1 2026 | 1.32M | $68.16M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding SUPN
- BlackRock Inc 9.35M sh · $434.87M · Q2 2026
- Vanguard Group 6.05M sh · $300.61M · Q4 2025
- Millennium Management 3.85M sh · $179.21M · Q2 2026
- Geode Capital Management 1.57M sh · $73.04M · Q2 2026
- Renaissance Technologies 1.48M sh · $68.75M · Q2 2026
- Citadel Advisors 1.42M sh · $66.02M · Q2 2026
- Two Sigma Investments 1.18M sh · $55.09M · Q2 2026
- Morgan Stanley 876.84K sh · $40.78M · Q2 2026
- Goldman Sachs Group 819.43K sh · $38.11M · Q2 2026
- D. E. Shaw & Co 767.67K sh · $35.70M · Q2 2026
- Northern Trust Corp 733.37K sh · $34.11M · Q2 2026
- Charles Schwab Investment Management 703.55K sh · $32.72M · Q2 2026